Clinical Trials Browser

Has results × Myasthenia Gravis × satralizumab × Clear all

NCT04963270 2025-02-28

A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis

Phase 3 Terminated

188 enrolled 40 charts

Myasthenia Gravis